Combination of a pyrimidylaminobenzamide and an MTOR kinase inhibitor

Details for Australian Patent Application No. 2006271650 (hide)

International Classifications

Event Publications

14 February 2008 PCT application entered the National Phase

PCT publication WO2007/010012 Priority application(s): WO2007/010012

6 January 2011 Application Accepted

Published as AU-B-2006271650

10 February 2011 Corrigenda

Applications Accepted - Name Index Under the name Novartis AG, Application No. 2006271650, under INID (54) correct the title to read Combination of a pyrimidylaminobenzamide and an mTOR kinase inhibitor

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.